Deep within the source code of this online multiplayer game lies an enigmatic number that puzzles and inspires experts to this day ...

A mathematical trick speeds up seismic calculations for earthquake simulations and could revolutionize earthquake preparedness.

Across the country, states are passing new laws aimed at improving math teaching—mandating that schools intervene early to ...

The US is making plans to try to intercept a fleeing oil tanker that Russia has claimed jurisdiction over, according to four people familiar with the matter, setting up a possible confrontation ...

After a long run of regulatory stumbles and the recent withdrawal of its lone commercial drug from the U.S. market, Intercept Pharmaceuticals is implementing a restructuring and rounds of job cuts in ...

U.S. military jets on Saturday intercepted a civilian aircraft that flew through temporarily restricted airspace over Palm Beach, Florida, where President Trump's Mar-a-Lago estate is located, ...

Anna Coren, CBS News foreign correspondent based in Hong Kong, is an Emmy Award-winning international correspondent who covers the Asia-Pacific region. East China Sea — Over the deep blue waters of ...

U.S. fighter jets scrambled Wednesday to intercept four Russian warplanes off the coast of Alaska, the North American Aerospace Defense Command (NORAD) said Thursday. NORAD said in a statement it ...

U.S. fighter jets were scrambled Wednesday to identify and intercept four Russian warplanes flying near Alaska, the North American Aerospace Defense Command said in a statement. NORAD said two Russian ...

While the path for any drug to go from lab research to commercialization takes years, Intercept Pharmaceuticals now stands as another example that a product’s market exit can also be long and winding.

Please provide your email address to receive an email when new articles are posted on . Intercept has voluntarily withdrawn its lone product, Ocaliva, from U.S. market for primary biliary cholangitis.

Sept 11 (Reuters) - Intercept Pharmaceuticals said on Thursday it is withdrawing its liver disease drug from the U.S. market following a request from the Food and Drug Administration. This comes as ...